Cargando…

Nutritional Sensor REDD1 in Cancer and Inflammation: Friend or Foe?

Regulated in Development and DNA Damage Response 1 (REDD1)/DNA Damage-Induced Transcript 4 (DDIT4) is an immediate early response gene activated by different stress conditions, including growth factor depletion, hypoxia, DNA damage, and stress hormones, i.e., glucocorticoids. The most known function...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhidkova, Ekaterina M., Lylova, Evgeniya S., Grigoreva, Diana D., Kirsanov, Kirill I., Osipova, Alena V., Kulikov, Evgeny P., Mertsalov, Sergey A., Belitsky, Gennady A., Budunova, Irina, Yakubovskaya, Marianna G., Lesovaya, Ekaterina A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456073/ https://www.ncbi.nlm.nih.gov/pubmed/36077083 http://dx.doi.org/10.3390/ijms23179686

Ejemplares similares

A Brief Overview of the Paradoxical Role of Glucocorticoids in Breast Cancer
por: Zhidkova, Ekaterina M, et al.
Publicado: (2020)

Insights into the Mechanism of Curaxin CBL0137 Epigenetic Activity: The Induction of DNA Demethylation and the Suppression of BET Family Proteins
por: Maksimova, Varvara, et al.
Publicado: (2023)

REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids
por: Baida, Gleb, et al.
Publicado: (2015)

Prevention of therapy-related malignances in cancer survivors
por: Belitsky, Gennady A., et al.
Publicado: (2019)

The long winding road to the safer glucocorticoid receptor (GR) targeting therapies
por: Lesovaya, Ekaterina A., et al.
Publicado: (2022)

Current Approaches for Personalized Therapy of Soft Tissue Sarcomas
por: Kirsanov, Kirill I., et al.
Publicado: (2020)

HeLa TI cell-based assay as a new approach to screen for chemicals able to reactivate the expression of epigenetically silenced genes
por: Maksimova, Varvara, et al.
Publicado: (2021)

Toxicological Properties of 7-Methylguanine, and Preliminary Data on its Anticancer Activity
por: Kirsanov, Kirill, et al.
Publicado: (2022)

Effects of G-Quadruplex-Binding Plant Secondary Metabolites on c-MYC Expression
por: Zenkov, Roman G., et al.
Publicado: (2022)

Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats
por: Lesovaya, Ekaterina A., et al.
Publicado: (2015)

Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo
por: Fetisov, Timur I., et al.
Publicado: (2023)

Molecular Mechanisms of Anticancer Activity of N-Glycosides of Indolocarbazoles LCS-1208 and LCS-1269
por: Zenkov, Roman G., et al.
Publicado: (2021)

Minor grove binding ligands disrupt PARP-1 activation pathways
por: Kirsanov, Kirill I., et al.
Publicado: (2014)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

Analysis of Multiple Drug Resistance Mechanism in Different Types of Soft Tissue Sarcomas: Assessment of the Expression of ABC-Transporters, MVP, YB-1, and Analysis of Their Correlation with Chemosensitivity of Cancer Cells
por: Moiseeva, Natalia I., et al.
Publicado: (2022)

Friend and Foe
Publicado: (1890)

Soft Tissue Sarcoma Study: Association of Genetic Alterations in the Apoptosis Pathways with Chemoresistance to Doxorubicin
por: Kirilin, Evgeny M., et al.
Publicado: (2022)

Discovery of Compound A – a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activity
por: Lesovaya, Ekaterina, et al.
Publicado: (2015)

Phytoestrogens. Friends or foes?
por: Barrett, J
Publicado: (1996)

Polypill—Friend or Foe?
por: Rishi, Rakesh Kumar
Publicado: (2011)

Antioxidants - friend or foe?
por: Meffert, Hans
Publicado: (2008)

Inflammation: Friend and Foe
por: Kjekshus, John
Publicado: (2015)

Leukocytes: friend or foe
por: Bellingan, G
Publicado: (2000)

Viruses: Friends or foes
por: Michán, Carmen, et al.
Publicado: (2021)

Sphingolipids: Friends or Foes?
por: Hayashi, Hiroshi
Publicado: (2022)

Gabapentin—Friend or foe?
por: Russo, Marc, et al.
Publicado: (2022)

Bacterial toxins: friends or foes?
por: Schmitt, C K, et al.
Publicado: (1999)

Perspectives of Cell Sensitivity/Resistance Assay in Soft Tissue Sarcomas Chemotherapy
por: Fetisov, Timur I., et al.
Publicado: (2023)

Alcohol and Apoptosis: Friends or Foes?
por: Rodriguez, Ana, et al.
Publicado: (2015)

FACT is a sensor of DNA torsional stress in eukaryotic cells
por: Safina, Alfiya, et al.
Publicado: (2017)

Sexual dimorphism in atrophic effects of topical glucocorticoids is driven by differential regulation of atrophogene REDD1 in male and female skin
por: Baida, Gleb, et al.
Publicado: (2020)

Estrogen and COVID-19: friend or foe?
por: Di Vincenzo, A., et al.
Publicado: (2021)

Newton, his friends and his foes
por: Hall, A Rupert
Publicado: (1993)

RAD52: Viral Friend or Foe?
por: Hendrickson, Eric A.
Publicado: (2020)

Microbiota of the gastrointestinal tract: Friend or foe?
por: Senchukova, Marina A
Publicado: (2023)

Oxygen, the lung and the diver: friends and foes?
por: van Ooij, Pieter-Jan A.M., et al.
Publicado: (2016)

Internal thoracic vein: friend or foe?
por: Roubelakis, A, et al.
Publicado: (2014)

Dairy and cardiovascular health: Friend or foe?
por: Markey, O, et al.
Publicado: (2014)

Media and breastfeeding: Friend or foe?
por: Brown, Jane D, et al.
Publicado: (2008)

Friend to the brain, foe to the spine
por: Maxmen, Amy
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_6djq21muo9hbv5g8vphr8iav20